Chronic hepatitis C (CHC) patients with cirrhosis may be at risk of hepatic decompensation and death when treated with alpha interferons, including PEGASYS.

合化的慢性丙（CHC）患者接受α干扰素包派罗欣治疗时存在功能失代偿风险。